CRP and neoplasm: Therefore, certain immune-inflammatory indicators, such as C-reactive protein (CRP) (35), platelet-lymphocyte ratio (PLR) (36), neutrophil-lymphocyte ratio (NLR) (37), lymphocyte-monocyte ratio (LMR) (38), albumin (39), and plasma fibrinogen levels (40), have been reported as potential biomarkers for diagnosing and predicting the prognosis of tumor patients.